Stepwise examination for differential diagnosis of primary lung cancer and breast cancer relapse presenting as a solitary pulmonary nodule in patients after mastectomy

Journal of Surgical Oncology

Volumn 98, Issue 7, 2008, Pages 510-514

  Okasaka, Toshiki ^a,b   Usami, Noriyasu ^a   Mitsudomi, Tetsuya ^b   Yatabe, Yasushi ^b   Matsuo, Keitaro ^b   Yokoi, Kohei ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

Author keywords

Differential diagnosis; Metastatic breast cancer; Pulmonary surgical procedure; Solitary pulmonary nodule

Indexed keywords

ANTINEOPLASTIC AGENT; CA 15-3 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; HORMONE; MAMMAGLOBIN;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER HORMONE THERAPY; CANCER RELAPSE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE FREE SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LUNG NODULE; MASTECTOMY; METASTASECTOMY; METASTASIS; MINIMALLY INVASIVE SURGERY; NEEDLE BIOPSY; POSTOPERATIVE COMPLICATION; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SURGICAL TECHNIQUE; TRANSBRONCHIAL BIOPSY;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANTIBODIES; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEASIBILITY STUDIES; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG; LUNG NEOPLASMS; MASTECTOMY; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; RADIOGRAPHY, INTERVENTIONAL; RECEPTORS, ESTROGEN; SOLITARY PULMONARY NODULE; TOMOGRAPHY, X-RAY COMPUTED; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; UTEROGLOBIN;

EID: 56649085331     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21149     Document Type: Article

References (24)

1. Moulder S, Hortobagyi GN: Advances in the treatment of breast cancer. Clin Pharmacol Ther 2008;83:26-36.
2. Parkin DM, Whelan SL, Ferlay L, et al.: Cancer incidence in five continents VII. Lyon: IARC Publications; 1997. pp 858-859.
3. Parkin DM, Whelan SL, Ferlay L, et al.: Cancer incidence in five continents VIII. Lyon: IARC Publications; 2002. pp 603-605.
4. Raymond JS, Hogue CJR: Multiple primary tumors in women following breast cancer 1973-2000. Br J Cancer 2006;94:1745-1750.
5. McDonald ML, Deschamps C, Ilstrup DM, et al.: Pulmonary resection for metastatic breast cancer. Ann Thorac Surg 1994;58:1599-1602.
6. Tanaka F, Li M, Hanaoka N, et al.: Surgery for pulmonary nodules in breast cancer patients. Ann Thorac Surg 2005;79:1711-1714; discussion 1714-1715.
7. Friedel G, Pastorino U, Ginsberg RJ, et al.: Results of lung metastasectomy from breast cancer: Prognostic criteria on the basis of 467 cases of the International Registry of Lung Metastases. Eur J Cardiothorac Surg 2002;22:335-344.
8. Chang EY, Johnson W, Karamlou K, et al.: The evaluation and treatment implications of isolated pulmonary nodules in patients with a recent history of breast cancer. Am J Surg 2006;191:641-645.
9. Planchard D, Soria JC, Michiels S, et al.: Uncertain benefit from surgery in patients with lung metastases from breast carcinoma. Cancer 2004;100:28-35.
10. Guarneri V, Conte PF: The curability of breast cancer and the treatment of advanced disease. Eur J Nucl Med Mol Imaging 2004;31:S149-S161.
11. Giordano SH, Buzdar AU, Smith TL, et al.: Is breast cancer survival improving? Cancer 2004;100:44-52.
12. Gennari A, Conte P, Rosso R, et al.: Survival of metastatic breast carcinoma patients over a 20-year period: A retrospective analysis based on individual patient data from six consecutive studies. Cancer 2005;104:1742-1750.
13. Slamon DJ, Leyland-Jones B, Shak S, et al.: Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl JMed 2001;344:783-792.
14. Rena O, Papalia E, Ruffini E, et al.: The role of surgery in the management of solitary pulmonary nodule in breast cancer patients. Eur J Surg Oncol 2007;33:546-550.
15. Mountain CF: Revisions in the international system for staging lung cancer. Chest 1997;111:1710-1717.
16. Naruke T, Goya T, Tsuchiya R, et al.: Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg 1988;96:440-447.
17. Lazzaro D, Price M, Felice M, et al.: The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 1991;113:1093-1104.
18. Yatabe Y, Mitsudomi T, Takahashi T. TTF-1 expression in pulmonary adenocarcinomas. Am J Surg Pathol 2002;26:767-773.
19. Moldvay J, Jackel M, Bogos K, et al.: The role of TTF-1 in differentiating primary and metastatic lung adenocarcinomas. Pathol Oncol Res 2004;10:85-88.
20. Khoor A, Whitsett JA, Stahlman MT, et al.: Utility of surfactant protein B precursor and thyroid transcription factor 1 in differentiating adenocarcinoma of the lung from malignant mesothelioma. Hum Pathol 1999;30:695-700.
21. Raab SS, Berg LC, Swanson PE, et al.: Adenocarcinoma in the lung in patients with breast cancer. Am J Clin Pathol 1993;100:27-35.
22. Kaufmann O, Deidesheimer T, Muehlenberg M, et al.: Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sites. Histopathology 1996;29:233-240.
23. Koga T, Horio Y, Mitsudomi T, et al.: Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE data. J Mol Diagn 2004;6:90-95.
24. Sasaki E, Tsunoda N, Hatanaka Y, et al.: Breast-specific expression of MGB1/mammaglobin: An examination of 480 tumors from various organs and clinocopathological analysis of MGB1-positive breast cancers. Modern Pathol 2007;20:208-214.